title: Bone marrow leukaemic transformation of myelodysplastic syndrome revealed by a cutaneous Langerhans cell infiltrate: partial response to azacitidine.
authors.affiliation: Université Paris Diderot, Laboratoire de Pathologie, UMR-S 728, Paris, France, INSERM U728, city>Paris, France, Laboratoire de Pathologie.
authors.forename: Amélie
authors.initials: A
authors.lastname: Osio
authors.forename: Fatima
authors.initials: F
authors.lastname: Elfatoiki
authors.forename: Emanuel
authors.initials: E
authors.lastname: Raffoux
authors.forename: Marie-Dominique
authors.initials: MD
authors.lastname: Vignon-Pennamen
authors.forename: Adrienne
authors.initials: A
authors.lastname: de Labarthe
authors.forename: Florence
authors.initials: F
authors.lastname: Cordoliani
authors.forename: Tony
authors.initials: T
authors.lastname: Petrella
authors.forename: Martine
authors.initials: M
authors.lastname: Bagot
authors.forename: Anne
authors.initials: A
authors.lastname: Janin
authors.forename: Maxime
authors.initials: M
authors.lastname: Battistella
authors.forename: Jean David
authors.initials: JD
authors.lastname: Bouaziz
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D001374:Azacitidine / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology*; D002471:Cell Transformation, Neoplastic; D006801:Humans; D007801:Langerhans Cells / Q000473:pathology; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000150:complications / Q000473:pathology*; D012871:Skin Diseases / Q000209:etiology / Q000473:pathology*
chemical_list: D000964:Antimetabolites, Antineoplastic; D001374:Azacitidine